生物活性 | |||
---|---|---|---|
描述 | Defactinib (VS-6063) suppresses FAK phosphorylation at the Tyr397 site in both time- and dose-responsive ways. RPPA analysis reveals that Defactinib decreases AKT and YB-1 levels in taxane-resistant cell lines. Defactinib's inhibition of pFAK (Tyr397) expression across all cell lines is statistically significant and dose-dependent. Within 3 hours, Defactinib reduces pFAK (Tyr397) expression, which starts to reappear by 48 hours[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.83mL 0.37mL 0.18mL |
9.14mL 1.83mL 0.91mL |
18.28mL 3.66mL 1.83mL |
参考文献 |
---|